4//SEC Filing
MARTIN JOHN C 4
Accession 0001127602-19-004859
CIK 0000882095other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:52 PM ET
Size
8.2 KB
Accession
0001127602-19-004859
Insider Transaction Report
Form 4
MARTIN JOHN C
DirectorChairman and CEO
Transactions
- Award
Common Stock
2019-02-06+7,745→ 2,885,507 total - Tax Payment
Common Stock
2019-02-06$68.75/sh−13,787$947,856→ 2,887,225 total - Award
Common Stock
2019-02-06+15,505→ 2,901,012 total
Footnotes (2)
- [F1]Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.
- [F2]Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001190578
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:52 PM ET
- Size
- 8.2 KB